Multicenter Analysis of Transplant Outcomes for the Newly Defined MDS/AML Entity in the 2022 ICC: Risk Stratification and Comparison with AML

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Yuhua Ru, Mimi Xu, Mengqi Xiang, Yuqing Tu, Miao Miao, Yue Han, Xiaowen Tang, Huiying Qiu, Suning Chen, Ying Wang, Shengli XUE, Xiaoli Li
+20 more Lian Bai, Jun Chen, Jun Chen, Shanshan Jiang, Xiaojin Wu, Jinjin Zhu, Jiaxin Li, Yutong Liu, Fang Chen, Jiong Zhang, Yang Xu, Yi Fan, Xiang Zhang, Tiemei Song, Qi Qu, Qi Qu, Depei Wu, Depei Wu, Jia Chen, Jia Chen
DOI: 10.1016/j.jtct.2026.04.002
Cited by: 1
References: 5

Fields of Study & Subjects

Acute Myeloid Leukemia Research Hematopoietic Stem Cell Transplantation Acute Lymphoblastic Leukemia research

Publication details

Journal / source
Transplantation and Cellular Therapy
Publisher
Elsevier BV
Volume
32
Issue
8
Pages
939.e1–939.e4
Publication date
24 April 2026
Language
EN